Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care.

Haywood, D; Henry, M; Dauer, E; Lederman, O; Farley, M; Henneghan, AM; O'Connor, M; Jefford, M; Rossell, SL; Hart, NH

Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care.

Haywood, D

Henry, M Dauer, E Lederman, O

Farley, M Henneghan, AM O'Connor, M Jefford, M Rossell, SL Hart, NH

Permalink

Publisher:: SPRINGER
Publication Type:: Journal Article
Citation:: Support Care Cancer, 2024, 32, (7), pp. 480
Issue Date:: 2024-07-02

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (656 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Haywood, D https://orcid.org/0000-0002-9317-4135
dc.contributor.author	Henry, M
dc.contributor.author	Dauer, E
dc.contributor.author	Lederman, O https://orcid.org/0000-0002-0321-5723
dc.contributor.author	Farley, M
dc.contributor.author	Henneghan, AM
dc.contributor.author	O'Connor, M
dc.contributor.author	Jefford, M
dc.contributor.author	Rossell, SL
dc.contributor.author	Hart, NH
dc.date.accessioned	2024-07-24T07:51:45Z
dc.date.available	2024-06-25
dc.date.available	2024-07-24T07:51:45Z
dc.date.issued	2024-07-02
dc.identifier.citation	Support Care Cancer, 2024, 32, (7), pp. 480
dc.identifier.issn	0941-4355
dc.identifier.issn	1433-7339
dc.identifier.uri	http://hdl.handle.net/10453/179835
dc.description.abstract	A significant proportion of cancer survivors will experience some form of mental health compromise across domains including mood, anxiety, psychosis, eating disorders, and substance use. This psychopathology within cancer survivors is related to a range of negative outcomes and can also have a substantial negative impact on quality of life. Along with psychopathology, cognitive impairments are also commonly experienced, resulting in deficits in memory, reasoning, decision-making, speed of processing, and concentration, collectively referred to as cancer-related cognitive impairment (CRCI). Within the non-oncology literature, cognitive deficits are consistently demonstrated to be a key transdiagnostic aetiological feature of psychopathology, functionally contributing to the development and perpetuation of symptoms. Whilst there is an acknowledgement of the role mental health concerns might play in the development of and perception of CRCI, there has been limited acknowledgement and research exploring the potential for CRCI to functionally contribute toward the development of transdiagnostic psychopathology in cancer survivors beyond simply psychosocial distress. Given the theoretical and empirical evidence suggesting cognitive deficits to be an aetiological factor in psychopathology, we provide a rationale for the potential for CRCI to be a factor in the development and perpetuation of transdiagnostic psychopathology in cancer survivors. This potential functional association has significant implications for risk identification, prevention, treatment, and supportive cancer care approaches regarding psychopathology in cancer survivorship. We conclude by providing directions for future research in this area.
dc.format	Electronic
dc.language	eng
dc.publisher	SPRINGER
dc.relation.ispartof	Support Care Cancer
dc.relation.isbasedon	10.1007/s00520-024-08696-9
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	11 Medical and Health Sciences, 17 Psychology and Cognitive Sciences
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.classification	32 Biomedical and clinical sciences
dc.subject.classification	42 Health sciences
dc.subject.classification	52 Psychology
dc.subject.mesh	Humans
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Cognitive Dysfunction
dc.subject.mesh	Neoplasms
dc.subject.mesh	Quality of Life
dc.subject.mesh	Mental Disorders
dc.subject.mesh	Humans
dc.subject.mesh	Neoplasms
dc.subject.mesh	Mental Disorders
dc.subject.mesh	Quality of Life
dc.subject.mesh	Cognitive Dysfunction
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Humans
dc.subject.mesh	Cancer Survivors
dc.subject.mesh	Cognitive Dysfunction
dc.subject.mesh	Neoplasms
dc.subject.mesh	Quality of Life
dc.subject.mesh	Mental Disorders
dc.title	Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care.
dc.type	Journal Article
utslib.citation.volume	32
utslib.location.activity	Germany
utslib.for	11 Medical and Health Sciences
utslib.for	17 Psychology and Cognitive Sciences
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/Strength - HPRC - Human Performance Research Centre
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
dc.date.updated	2024-07-24T07:51:42Z
pubs.issue	7
pubs.publication-status	Published online
pubs.volume	32
utslib.citation.issue	7

Abstract:

A significant proportion of cancer survivors will experience some form of mental health compromise across domains including mood, anxiety, psychosis, eating disorders, and substance use. This psychopathology within cancer survivors is related to a range of negative outcomes and can also have a substantial negative impact on quality of life. Along with psychopathology, cognitive impairments are also commonly experienced, resulting in deficits in memory, reasoning, decision-making, speed of processing, and concentration, collectively referred to as cancer-related cognitive impairment (CRCI). Within the non-oncology literature, cognitive deficits are consistently demonstrated to be a key transdiagnostic aetiological feature of psychopathology, functionally contributing to the development and perpetuation of symptoms. Whilst there is an acknowledgement of the role mental health concerns might play in the development of and perception of CRCI, there has been limited acknowledgement and research exploring the potential for CRCI to functionally contribute toward the development of transdiagnostic psychopathology in cancer survivors beyond simply psychosocial distress. Given the theoretical and empirical evidence suggesting cognitive deficits to be an aetiological factor in psychopathology, we provide a rationale for the potential for CRCI to be a factor in the development and perpetuation of transdiagnostic psychopathology in cancer survivors. This potential functional association has significant implications for risk identification, prevention, treatment, and supportive cancer care approaches regarding psychopathology in cancer survivorship. We conclude by providing directions for future research in this area.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/179835